Novo Nordisk A/S vs Snowflake Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Snowflake Inc trades at $271.7 (market cap $95.09B). The key difference: Novo Nordisk A/S is far larger — about 2.3× Snowflake Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Snowflake Inc pays none. Which is the better fit depends on your goals.
| NVO | SNOW | |
|---|---|---|
Market Cap | $220.53B | $95.09B |
Sector | Health | Technology |
52-Week High | $71.70 | $280.16 |
52-Week Low | $35.29 | $121.11 |
Enterprise Value | $239.49B | $94.90B |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →